Mutational pathways and genetic barriers to CXCR4-mediated entry by human immunodeficiency virus type 1 |
| |
Authors: | Huang Wei Frantzell Arne Toma Jonathan Fransen Signe Whitcomb Jeannette M Stawiski Eric Petropoulos Christos J |
| |
Affiliation: | Monogram Biosciences, South San Francisco, CA, USA |
| |
Abstract: | To examine mutational pathways that lead to CXCR4 use of HIV-1, we analyzed the genotypic and phenotypic characteristics of envelope sequences from a large panel of patient virus populations and individual clones containing different V3 mutations. Basic amino acid substitutions at position 11 were strong determinants of CXCR4-mediated entry but required multiple compensatory mutations to overcome associated reductions in infectivity. In contrast, basic amino acid substitutions at position 25, or substitutions at positions 6-8 resulting in the loss of a potential N-linked glycosylation site, contributed to CXCR4-mediated entry but required additional substitutions acting cooperatively to confer efficient CXCR4 use. Our assumptions, based upon examination of patient viruses, were largely confirmed by characterizing the coreceptor utilization of five distinct panels of isogenic envelope sequences containing V3 amino acid substitutions introduced by site-directed mutagenesis. These results further define the mutational pathways leading to CXCR4 use and their associated genetic barriers. |
| |
Keywords: | HIV-1 V3 Coreceptor Tropism X4 R5 Dual CXCR4 CCR5 CCR5 antagonist |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|